KRUNG THEP MAHA NAKHON, Thailand, Sept. 07, 2026 (GLOBE NEWSWIRE) — From September 2 to 4, Vitafoods Asia, the international nutraceutical exhibition, was held in Bangkok, Thailand. NYO3 made its third consecutive appearance at the show, globally debuting a new product line powered by Norwegian innovative ingredient LPC, and simultaneously announcing the launch of its “Global Partner Program” to further expand its overseas cooperation network and steadily advance its globalization strategy.
NYO3 has entered into a strategic partnership with Aker BioMarine to launch the LPC series. The two core new products precisely address different scenario needs. Among them, NYO3 Brain Health Support focuses on brain aging issues, utilizing pure LPC brain nutrients for precise delivery to the brain. The newly upgraded NYO3 LPC Omega‑3 Krill Oil innovatively opens a new pathway for endogenous anti‑aging. Built on 100% pure Antarctic krill oil, it is scientifically formulated with added LPC brain nutrients, catering to working professionals and sub‑health populations, achieving triple synergistic support for the heart, brain, and liver.
Additionally, NYO3 officially launched its “Global Partner Program” at Vitafoods Asia, aiming to establish deep‑rooted collaborations with distributors, channel platforms, and industry partners across various countries. During the exhibition, NYO3 signed its first batch of global partners from Indonesia, Thailand, and Vietnam, jointly building a win‑win regional ecosystem.
Looking ahead, NYO3 will continue to deepen its commitment to Norwegian anti‑aging technology, strictly control product quality, and reinforce its global supply chain capabilities. Always centered on anti‑aging, the company is dedicated to providing consumers worldwide with more scientific and effective nutritional solutions.
Company: NYO3 International AS
Website: https://nyo3.com
Contact Person: Derek Sung
Email: [email protected]
City: Krung Thep Maha Nakhon
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d066ed5c-1d89-44aa-a6bc-aef098f1e9ba
https://www.globenewswire.com/NewsRoom/AttachmentNg/47fead10-f687-4ff6-8824-42fc0c9863fb
https://www.globenewswire.com/NewsRoom/AttachmentNg/9645c7eb-5e27-4103-8a1a-f6b242b149e9
